{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:18:51Z","timestamp":1777558731934,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.tcm.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T18:06:37Z","timestamp":1676052397000},"page":"225-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-2306","authenticated-orcid":false,"given":"Yoga","family":"Waranugraha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ti","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2023.02.002_bib0001","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2023.02.002_bib0002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2023.02.002_bib0003","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2023.02.002_bib0004","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2023.02.002_bib0005","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2023.02.002_bib0006","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2023.02.002_bib0007","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.4244\/EIJ-D-19-00128","article-title":"Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study","volume":"15","author":"Cresti","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.tcm.2023.02.002_bib0008","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2023.02.002_bib0009","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s43044-021-00194-1","article-title":"Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences","volume":"73","author":"Waranugraha","year":"2021","journal-title":"Egypt Heart J"},{"key":"10.1016\/j.tcm.2023.02.002_bib0010","first-page":"1091","article-title":"Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation","volume":"19","author":"Hellfritzsch","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2023.02.002_bib0011","first-page":"899","article-title":"Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark","volume":"38","author":"Gadsb\u00f8ll","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2023.02.002_bib0012","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjcard.2019.10.047","article-title":"Dabigatran persistence and outcomes following discontinuation in atrial fibrillation patients from the GLORIA-AF Registry","volume":"125","author":"Paquette","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2023.02.002_bib0013","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.tcm.2023.02.002_bib0014","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2023.02.002_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term Warfarin therapy","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2023.02.002_bib0016","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2023.02.002_bib0017","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.tcm.2023.02.002_bib0018","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1524839919893361","article-title":"A review of the PubMed PICO tool: using evidence-based practice in health education","volume":"21","author":"Brown","year":"2020","journal-title":"Health Promot Pract"},{"key":"10.1016\/j.tcm.2023.02.002_bib0019","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.tcm.2023.02.002_bib0020","first-page":"355:i4919.","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.tcm.2023.02.002_bib0021","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.tcm.2023.02.002_bib0022","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.tcm.2023.02.002_bib0023","series-title":"Modern meta-analysis: review and update of methodologies","author":"Cleophas","year":"2017"},{"key":"10.1016\/j.tcm.2023.02.002_bib0024","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.tcm.2023.02.002_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/bmj.39057.406644.68","article-title":"What is heterogeneity and is it important?","volume":"334","author":"Fletcher","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.tcm.2023.02.002_bib0026","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ipej.2020.12.005","article-title":"The benefit of atrioventricular junction ablation for permanent atrial fibrillation and heart failure patients receiving cardiac resynchronization therapy: an updated systematic review and meta-analysis","volume":"21","author":"Waranugraha","year":"2021","journal-title":"Indian Pacing Electrophysiol J"},{"key":"10.1016\/j.tcm.2023.02.002_bib0027","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ihj.2020.11.004","article-title":"Additional complex fractionated atrial electrogram ablation does not improve the outcomes of non-paroxysmal atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"73","author":"Waranugraha","year":"2021","journal-title":"Indian Heart J"},{"key":"10.1016\/j.tcm.2023.02.002_bib0028","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/jpm12020298","article-title":"A systematic review and meta-analysis of the direct comparison of second-generation cryoballoon ablation and contact force-sensing radiofrequency ablation in patients with paroxysmal atrial fibrillation","volume":"12","author":"Waranugraha","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.tcm.2023.02.002_bib0029","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/joa3.12590","article-title":"The superiority of high-power short-duration radiofrequency catheter ablation strategy for atrial fibrillation treatment: a systematic review and meta-analysis study","volume":"37","author":"Waranugraha","year":"2021","journal-title":"J Arrhythmia"},{"key":"10.1016\/j.tcm.2023.02.002_bib0030","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00392-021-01983-z","article-title":"Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation","volume":"111","author":"Ding","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.tcm.2023.02.002_bib0031","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4244\/EIJ-D-19-00507","article-title":"Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk","volume":"15","author":"Godino","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.tcm.2023.02.002_bib0032","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2023.02.002_bib0033","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2023.02.002_bib0034","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.repc.2020.07.021","article-title":"Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke","volume":"40","author":"Paiva","year":"2021","journal-title":"Rev Port Cardiol Engl Ed"},{"key":"10.1016\/j.tcm.2023.02.002_bib0035","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.tcm.2023.02.002_bib0036","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.tcm.2023.02.002_bib0037","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2023.02.002_bib0038","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2023.02.002_bib0039","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2023.02.002_bib0040","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2023.02.002_bib0041","article-title":"Left atrial appendage occlusion in patients with atrial fibrillation: focus on current evidence and commercially available devices","volume":"5:53","author":"Maurina","year":"2021","journal-title":"Mini Invasive Surg"},{"key":"10.1016\/j.tcm.2023.02.002_bib0042","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022274","article-title":"Left atrial appendage occlusion for stroke prevention in nonvalvular atrial fibrillation","volume":"10","author":"Collado","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2023.02.002_bib0043","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2023.02.002_bib0044","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005841","article-title":"Percutaneous left atrial appendage closure is a reasonable option for patients with atrial fibrillation at high risk for cerebrovascular events","volume":"11","author":"Teiger","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2023.02.002_bib0045","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2023.02.002_bib0046","first-page":"69","article-title":"Comparison of left atrial appendage occlusion versus non-vitamin-K antagonist oral anticoagulation in high-risk atrial fibrillation: an update","volume":"8","author":"Chen","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.tcm.2023.02.002_bib0047","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"137","author":"Hicks","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2023.02.002_bib0048","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/STROKEAHA.117.018825","article-title":"Cost-effectiveness of left atrial appendage closure with the WATCHMAN device compared with warfarin or non\u2013vitamin K antagonist oral anticoagulants for secondary prevention in nonvalvular atrial fibrillation","volume":"49","author":"Reddy","year":"2018","journal-title":"Stroke"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173823000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173823000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T01:14:47Z","timestamp":1715044487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173823000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1050173823000208"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2023.02.002","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}